Targeting tumour vasculature as a cancer treatment

DOI10.1080/17486700701298319MaRDI QIDQ2373333zbMATH OpenOpenAlexFDO

Authors Christopher A. Honstvet, P. F. Jones

Publication date 17 July 2007

Published in Computational \& Mathematical Methods in Medicine (Search for Journal in Brave)

Full work available at URL https://eudml.org/doc/224379

zbMATH Keywords

AngiogenesisAnti-angiogenesisVascular disrupting agentsVessel regression

Mathematics Subject Classification ID

Medical applications (general) (92C50)

Recommendations

• A therapy inactivating the tumor angiogenic factors
• Tumour-Induced Angiogenesis: A Review
• Optimal protocols for the anti-VEGF tumor treatment
• Quantitative model for efficient temporal targeting of tumor cells and neovasculature
• AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem
• Tumour angiogenesis model with variable vessels' effectiveness
• Modelling tumour-induced angiogenesis
• Angiogenesis and vascular remodelling in normal and cancerous tissues
• Tumour angiogenesis: the gap between theory and experiments

Cited in

(1)

• Anti-angiogenic therapy based on the binding to receptors

This page was built for publication: Targeting tumour vasculature as a cancer treatment

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2373333)